APA (7th ed.) Citation

SE, K., HS, J., TH, G., JH, L., JW, L., YJ, Y., . . . SG, A. (2023). High Platelet Reactivity Combined with CYP2C19 Genotype in Predicting Outcomes in East Asian Patients Undergoing Percutaneous Coronary Intervention. Clinical pharmacology and therapeutics, 114(5), 1104. https://doi.org/10.1002/cpt.3026

Chicago Style (17th ed.) Citation

SE, Kim, et al. "High Platelet Reactivity Combined with CYP2C19 Genotype in Predicting Outcomes in East Asian Patients Undergoing Percutaneous Coronary Intervention." Clinical Pharmacology and Therapeutics 114, no. 5 (2023): 1104. https://doi.org/10.1002/cpt.3026.

MLA (9th ed.) Citation

SE, Kim, et al. "High Platelet Reactivity Combined with CYP2C19 Genotype in Predicting Outcomes in East Asian Patients Undergoing Percutaneous Coronary Intervention." Clinical Pharmacology and Therapeutics, vol. 114, no. 5, 2023, p. 1104, https://doi.org/10.1002/cpt.3026.